Dimitrios Sarantakis
72Patents
12h-index
25Co-inventors
84Inventor score
Filing activity: Nov 4, 1974 → Dec 22, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US3941763A | PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH.sub.2 and intermediates | Emerging Cross-Sectional Technologies | 116 | Expired |
| US4253998A | Peptides related to somatostatin | Emerging Cross-Sectional Technologies | 36 | Expired |
| US6583139B1 | Compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 29 | Expired |
| US4282143A | Octapeptides lowering growth hormone | Emerging Cross-Sectional Technologies | 26 | Expired |
| US6492421B1 | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 | Chemistry; Metallurgy | 26 | Expired |
| US6492372B1 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 25 | Expired |
| US6479492B1 | Compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6436904B1 | Compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 18 | Expired |
| US6689781B2 | Phenylalanine derivatives as alpha 4 integrin inhibitors | Human Necessities | 15 | Expired |
| US4011182A | Cyclic undecapeptide analogs of somatostatin and intermediates | Emerging Cross-Sectional Technologies | 14 | Expired |
| US7378529B2 | Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6489300B1 | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 13 | Expired |
| US4253997A | Anti-ovulatory decapeptides | Emerging Cross-Sectional Technologies | 12 | Expired |
| US4209426A | Polypeptides related to somatostatin | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6794506B2 | 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 | Chemistry; Metallurgy | 10 | Expired |
| US4190575A | Polypeptides related to somatostatin | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6953802B2 | Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 | Chemistry; Metallurgy | 9 | Expired |
| US3933784A | Des-(ser.sup.13)-srif and intermediates | Emerging Cross-Sectional Technologies | 9 | Expired |
| US3998795A | (Acyl-D-.alpha.-amino acid-gly-gly-tyr-ala).sup.1 -somatostatin | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6291453A | 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 | Chemistry; Metallurgy | 8 | Expired |
| US3931140A | (H-gly-gly-tyr-ala).sup.1 -somatostatin | Emerging Cross-Sectional Technologies | 8 | Expired |
| US4178284A | Octapeptides | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6900179B2 | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 | Human Necessities | 8 | Expired |
| US4011207A | Des-(Ala.sup.1, Gly.sup.2,Lys.sup.4 -Srif, Des-(Ala.sup.1, Gly.sup.2, Lys.sup.4)-D-Trp.sup.8 -Srif and intermediates | Emerging Cross-Sectional Technologies | 7 | Expired |
| US4215039A | Somatostatin analogues | Emerging Cross-Sectional Technologies | 7 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.